pharmaceutical investing Aerie Pharmaceuticals Reports Topline Result from Rhopressa Mechanism of Action Study
Revolve Receives Approval from the Alberta Utilities Commission for the 15.7 MW Bright Meadows Solar Project
Silver47 Announces Closing of $23 Million Brokered LIFE Financing, Including Full Exercise of the Over-Allotment Option
FPX Nickel Announces Funding Contribution from Natural Resources Canada to Advance the Baptiste Nickel Project
